ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "rituximab and ultrasound"

  • Abstract Number: 2209 • 2018 ACR/ARHP Annual Meeting

    Fluorescence Optical Imaging Xiralite® Is Helpful in the Decision for Rituximab Re-Therapy in Patients with Rheumatoid Arthritis

    Sarah Ohrndorf1, Lisa Ridha2, Anne-Marie Glimm3, Gerd R. Burmester1, Gabriela Schmittat3, Marina Backhaus4 and Jens Klotsche5, 1Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 3Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany, 4Department of Rheumatology & Immunology, University Medicine Charit, Berlin, Germany, 5Program Area Epidemiology, German Rheumatism Research Center, Berlin, Germany

    Background/Purpose: Rituximab (RTX) is an effective and well-tolerated therapeutic option in rheumatoid arthritis (RA) patients with insufficient response to TNFα inhibitors. However, the exact time…
  • Abstract Number: 874 • 2017 ACR/ARHP Annual Meeting

    Effect of Rituximab on a Salivary Gland Ultrasound Score in Primary Sjögren’s Syndrome: Results of Multicentre Double-Blind Randomised Controlled Trial Sub-Study

    Benjamin Fisher1, Colin Everett2, John Rout3, John O'Dwyer2, Paul Emery4, Costantino Pitzalis5, Wan-Fai Ng6, Andrew Carr7, Colin Pease2, Elizabeth Price8, Nurhan Sutcliffe9, Jimmy Makdissi10, Anwar Tappuni10, Nagui Gendi11, Frances Hall12, Sharon Ruddock2, Catherine Fernandez2, Claire Hulme2, Kevin Davies13, Christopher J. Edwards14, Peter Lanyon15, Robert J. Moots16, Euthalia Roussou17, Linda Sharples18, Michele Bombardieri19 and Simon Bowman20, 1Rheumatology Research Group, University of Birmingham, Birmingham, United Kingdom, 2University of Leeds, Leeds, United Kingdom, 3Birmingham Dental Hospital, Birmingham, United Kingdom, 4NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 5Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 6Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, 7Newcastle Dental Hospital, Newcastle, United Kingdom, 8Great Western Hospital, Swindon, United Kingdom, 9Royal London Hospital, London, UK, London, United Kingdom, 10Barts Health NHS Trust, London, United Kingdom, 11Basildon and Thurrock University Hospital, Basildon, UK, Basildon, United Kingdom, 12School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom, 13University of Sussex, Brighton, United Kingdom, 14University of Southampton, Southampton, United Kingdom, 15University of Nottingham, Nottingham, United Kingdom, 16University of Liverpool, Liverpool, United Kingdom, 17Barking Havering and Redbridge University hospitals NHS Trust, London, United Kingdom, 18London School of Hygiene and Tropical Medicine, London, United Kingdom, 19Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK, London, United Kingdom, 20Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom

    Background/Purpose: B lymphocytes are important in the pathogenesis of primary Sjögren’s syndrome (PSS), but two phase III trials (TEARS and TRACTISS) of the B cell…
  • Abstract Number: 2519 • 2016 ACR/ARHP Annual Meeting

    Predictors of Flare in Rheumatoid Arthritis Patients Treated Preventively with Rituximab: A Prospective Study Using Ultrasound and Patient Reported Outcomes

    Mediola Ismajli1 and Maria J. Leandro2, 1Rheumatology, University College London Hospital, London, United Kingdom, 2Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom

    Title: Predictors of flare in rheumatoid arthritis patients treated preventively with rituximab: a prospective study using ultrasound and patient reported outcomes Background/Purpose: Rituximab (RTX) is…
  • Abstract Number: 492 • 2015 ACR/ARHP Annual Meeting

    Correlations Between Clinical, Laboratory and Ultrasound Joint Examination in RA Patients Treated with Rituximab

    Andreea Borangiu1, Diana Mazilu1, Ioana Saulescu1, Evelina Iachim2, Laura Grosanu1, Cosmin Constantinescu1, Andra Balanescu1, Denisa Predeteanu1, Ruxandra Ionescu1 and Daniela Opris1, 1University of Medicine and Pharmacy “Carol Davila”, Department of Internal Medicine and Rheumatology “Sf. Maria” Hospital, Bucharest, Romania, 2Carol Davila Medicine and Pharmacy University, Bucharest, Romania

    Background/Purpose: Correct assessment to biologics in rheumatoid arthritis (RA) patients is extremely important regarding future patient management. There is still an open debate about the…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies